DNA

0.00%

3.1¢ donaco international limited

Ann: Daily share buy back notice (Appendix 3E), page-5

First 5 Last

Share
Profile

Follow
KSD

1,876 Posts.

136

11/01/18

16:17

Post #: 30232709
Share

Originally posted by stlamc ↑

Share buyback? What share buyback? DNA's sp has slid back to near record lows, yet the company hasn't bought back any shares since mid-December. I thought the board was supposed to look after shareholder long-term interests. Consider these choice quotations:

"Buying the Company’s shares at recent prices represents an excellent opportunity to generate strong returns." (16 Oct 2017) NOTE: DNA's share price was 44cps when this statement occurred, 35% higher than its current price.

"Our announcement of a new dividend policy, and a regular dividend program , along with the planned share buy back , are all testament to the sustainable cash flow that Donaco generates and our commitment to building shareholder value. ” (29 Aug 2017)

"We also announced the implementation of a non-market share buyback program, which also commenced in October. Both initiatives are designed to reward our shareholders." (23 Nov 2017)

I doubt that shareholders currently believe in the board's claimed commitment to reward shareholders. Consider the following:

1. The price that "sophisticated investors" paid for DNA's cap raising shares in March 2014 has plummeted by more than 75% (then: $1.33; now: $0.325). No doubt, some of those professional investors suffered career damage over that buying decision.

2. Shareholders who bought into DNA's cap raising in March 2015 have had seen their capital shrunk almost in half (then: $0.60; now: $0.325).

3. DNA is now actively followed by only one investment house. A year or so ago, at least three brokers covered the stock.

I can understand that DNA wants to hold back much of its share buyback funds in case the conflict with on or more large shareholders results in stock dumping, but there are enough funds for the board to live up to its promises by systematically and regularly acquiring shares at these low prices.

Expand

Absolutely agree

DNA Price at posting: 32.5¢ Sentiment: Sell Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

BIT

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

As Nvidia cools, we're looking to Aussie AI

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

SBW

Shekel Brainweigh investor presentation webinar – the future of retail automation

LAM

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

OCC

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

PRU

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

RMX

Red Mountain Mining: record gold prices, two projects, two greenstone belts

CBA breaks trading record on strong day for Aussie financials

QML

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

There are more pages in this discussion • 21 more messages in this thread...

First 5 Last

Add DNA (ASX) to my watchlist

(20min delay)
Last 3.1¢		Change 0.000(0.00%)		Mkt cap ! $38.29M

Open	High	Low	Value	Volume
3.1¢	3.1¢	3.1¢	$186	6K

Buyers (Bids)

No.	Vol.	Price($)
2	149651	3.0¢

Sellers (Offers)

Price($)	Vol.	No.
3.1¢	30	1

View Market Depth

No.	Vol.	Price($)
1	33366	0.030
3	288000	0.029
2	160749	0.028
1	100000	0.027
1	20020	0.025

Price($)	Vol.	No.
0.031	30	1
0.032	142500	1
0.034	166666	1
0.035	58823	1
0.036	196414	2

Last trade - 15.28pm 06/09/2024 (20 minute delay)

DNA (ASX) Chart

Ann: Daily share buy back notice (Appendix 3E), page-5

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

As Nvidia cools, we're looking to Aussie AI

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

Shekel Brainweigh investor presentation webinar – the future of retail automation

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

Red Mountain Mining: record gold prices, two projects, two greenstone belts

CBA breaks trading record on strong day for Aussie financials

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Daily share buy back notice (Appendix 3E), page-5

Top Stories

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

As Nvidia cools, we're looking to Aussie AI

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

Shekel Brainweigh investor presentation webinar – the future of retail automation

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

Red Mountain Mining: record gold prices, two projects, two greenstone belts

CBA breaks trading record on strong day for Aussie financials

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News